| Name | Carbenicillin disodium |
| Description | Carbenicillin disodium (BRL-2064) is a broad-spectrum, semi-synthetic penicillin antibiotic with bactericidal and beta-lactamase resistant activity. |
| In vitro | In patients with cystic fibrosis, Carbenicillin (0.1μg/mL) exhibited no hypersensitivity drug reactions as measured by antibody levels. In chrysanthemums and TOBC, Carbenicillin (50 μg/mL) induced phytotoxicity in a concentration-dependent manner. |
| In vivo | Carbenicillin (125 mg/L) effectively suppresses the proliferation of soil bacteria, increases the volume of somatic embryos, and the number of somatic embryos per callus tissue. Within the callus tissue, Carbenicillin at concentrations of 250 mg/L to 500 mg/L can enhance the fresh weight of the tissue. At a higher concentration of 1 g/L, Carbenicillin reduces the germination frequency of leaf disc explants. Additionally, in vitro exposure of patients' isolated leukocytes to Carbenicillin (0.1 g/ml) does not result in histamine release. |
| Storage | Powder: -20°C for 3 years
Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : < 1 mg/mL (insoluble), The compound is unstable in solution, please use soon.
Ethanol : < 1 mg/mL (insoluble or slightly soluble), The compound is unstable in solution, please use soon.
DMSO : 62.5 mg/mL (147.98 mM), Sonication is recommended. The compound is unstable in solution, please use soon.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (4.74 mM), Sonication is recommended.
|
| Keywords | Inhibitor | inhibit | Cellwall | Cell wall | Carbenicillin disodium | Carbenicillin | BRL2064 | BRL 2064 | Bacterial | Antibiotic |
| Inhibitors Related | Neomycin sulfate | Adipic dihydrazide | Levulinic acid | D(+)-Raffinose pentahydrate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Doxycycline | Hyaluronic acid sodium (MW 20 kDa) | Dimethyl sulfoxide | Sodium diacetate | Sodium bicarbonate | BES |
United States
